Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
Clinical trial NCT00481767 · COMPLETED
Trial details
- NCT number
- NCT00481767
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2010-02-25
- Enrollment
- 676
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.